Peregrine Asset Advisers Inc. Makes New $1.52 Million Investment in Aspen Aerogels, Inc. (NYSE:ASPN)

Peregrine Asset Advisers Inc. purchased a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 54,897 shares of the construction company's stock, valued at approximately $1,520,000. Peregrine Asset Advisers Inc. owned 0.07% of Aspen Aerogels at the end of the most recent quarter.

A number of other large investors have also bought and sold shares of the company. Sigma Planning Corp purchased a new position in Aspen Aerogels in the 3rd quarter worth approximately $274,000. Mesirow Financial Investment Management Inc. purchased a new position in shares of Aspen Aerogels in the 3rd quarter worth about $252,000. Bridgewater Advisors Inc. increased its position in shares of Aspen Aerogels by 37.8% during the 3rd quarter. Bridgewater Advisors Inc. now owns 77,357 shares of the construction company's stock valued at $2,142,000 after purchasing an additional 21,218 shares during the last quarter. Pursue Wealth Partners LLC purchased a new position in shares of Aspen Aerogels during the 3rd quarter valued at about $222,000. Finally, Rice Hall James & Associates LLC raised its stake in shares of Aspen Aerogels by 19.9% during the third quarter. Rice Hall James & Associates LLC now owns 535,113 shares of the construction company's stock worth $14,817,000 after acquiring an additional 88,711 shares in the last quarter. 97.64% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Aspen Aerogels

In related news, CFO Ricardo C. Rodriguez sold 32,465 shares of the business's stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $30.14, for a total value of $978,495.10. Following the sale, the chief financial officer now directly owns 20,790 shares in the company, valued at approximately $626,610.60. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In related news, CEO Donald R. Young sold 63,355 shares of Aspen Aerogels stock in a transaction on Monday, September 30th. The shares were sold at an average price of $30.03, for a total value of $1,902,550.65. Following the transaction, the chief executive officer now directly owns 483,640 shares in the company, valued at $14,523,709.20. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Ricardo C. Rodriguez sold 32,465 shares of the company's stock in a transaction on Monday, August 26th. The stock was sold at an average price of $30.14, for a total transaction of $978,495.10. Following the transaction, the chief financial officer now owns 20,790 shares of the company's stock, valued at approximately $626,610.60. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 4.30% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on ASPN shares. Benchmark reissued a "buy" rating and issued a $14.00 target price on shares of Aspen Aerogels in a research note on Thursday, August 8th. Barclays initiated coverage on Aspen Aerogels in a research note on Tuesday, August 6th. They set an "overweight" rating and a $27.00 target price on the stock. TD Cowen lifted their price target on shares of Aspen Aerogels from $36.00 to $41.00 and gave the company a "buy" rating in a report on Tuesday, August 20th. Roth Mkm cut their target price on shares of Aspen Aerogels from $36.00 to $31.00 and set a "buy" rating on the stock in a research note on Friday. Finally, HC Wainwright reissued a "buy" rating and issued a $30.00 price target on shares of Aspen Aerogels in a research note on Wednesday, October 16th. One analyst has rated the stock with a sell rating, nine have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $28.90.

Aspen Aerogels Trading Up 4.2 %

NYSE ASPN traded up $0.69 on Monday, reaching $17.18. 1,286,058 shares of the company were exchanged, compared to its average volume of 1,569,542. The company has a current ratio of 3.46, a quick ratio of 2.82 and a debt-to-equity ratio of 0.23. The business's fifty day moving average price is $23.10 and its 200 day moving average price is $24.73. The stock has a market capitalization of $1.32 billion, a P/E ratio of 1,729.73 and a beta of 2.21. Aspen Aerogels, Inc. has a fifty-two week low of $8.79 and a fifty-two week high of $33.15.

Aspen Aerogels Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.